IP Library Granted Patent US 11,878,109
Granted Patent B2
US 11,878,109 · App. 16/875,906 · Granted Jan 23, 2024

Single-use nasal delivery device

Inventors: John D. Hoekman (Seattle, WA); Albert Kenneth Lavin (Seattle, WA); Christopher William Fuller (Seattle, WA); Craig Frederick Kohring (Seattle, WA)
Assignee: Impel Pharmaceuticals Inc.
A61M11/02A61M15/0065A61M2210/0618
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,878,109
App. No.
16/875,906
Granted
Jan 23, 2024
Kind
B2
Abstract

Embodiments relate to a single-use device for delivery of medication into a nasal cavity. In an embodiment, the device includes a propellant canister containing a propellant capable of propelling the compound to the nasal cavity. The propellant canister is displaceable between an unactuated position and an actuated position within the device. The device further includes an actuation element with an actuation lever configured to displace the propellant canister from the unactuated position to the actuated position. The device also includes a puncture element positioned to puncture the propellant canister, which causes the release of the propellant from the propellant canister. The device further includes a dose holding chamber containing a unit dose of the compound. The dose holding chamber is positioned such that propellant flows into the dose holding chamber and causes the compound to be propelled from the dose holding chamber to the nasal cavity of the user.

Claims (38)

1. A device for delivery of a compound to a nasal cavity, the device comprising:

a housing body;

a propellant canister in the housing body capable of containing a propellant which is different from the compound, the propellant canister displaceable between an unactuated position and an actuated position;

a puncture element in the housing body positioned to puncture the propellant canister and cause release of the propellant from the propellant canister when the propellant canister is displaced to the actuated position;

a diffuser in the housing body, acting as a one-way check-valve to diffuse the propellant upon its release from the propellant canister;

a dose holding chamber in the housing body, separated from the propellant canister, capable of containing a unit dose of the compound, the dose holding chamber positioned such that the released propellant flows into the dose holding chamber from the diffuser and causes the compound to be propelled from the dose holding chamber;

a nozzle positioned such that the compound flows through the nozzle upon being propelled from the dose holding chamber for delivery to the nasal cavity; and

an actuation element comprising an actuation lever, wherein actuation of the actuation lever is configured to displace the propellant canister from the unactuated position to the actuated position.

2. The device of claim 1 , wherein the actuation lever is an L-shaped lever arm, wherein a first member of the actuation lever is positioned to receive a contact force from an actuation button and a second member of the actuation lever perpendicular to the first member applies a contact force to the propellant canister upon actuation of the actuation button.

3. The device of claim 1 , wherein the actuation element comprises an actuation button exposed from the housing body, wherein depression of the actuation button in a direction towards the housing body drives the propellant canister into the puncture element, thereby puncturing the propellant canister.

4. The device of claim 1 , wherein the device further comprises a removeable cap configured to maintain the actuation element in an unactuated position.

5. The device of claim 1 , further comprising a lock configured to maintain the actuation element in an actuated position.

6. The device of claim 1 , further comprising a use indicator configured to provide an indication that the actuation element is in an actuated position.

7. The device of claim 1 , wherein the actuation element contains a sliding element exposed from the housing body, wherein the sliding element is slideable between an unactuated position that enables positioning of the propellant canister in the unactuated position and an actuated position that forces the propellant canister to the actuated position.

8. A device for delivery of a compound to a nasal cavity, the device comprising:

a propellant canister in a housing body capable of containing a propellant which is different from the compound, the propellant canister displaceable between an unactuated position and an actuated position;

a dose holding chamber, separated from the propellant canister, capable of containing a unit dose of the compound; a nozzle positioned such that the compound flows through the nozzle upon being propelled from the dose holding chamber by the propellant for delivery to the nasal cavity;

an actuation element comprising an actuation lever, wherein actuation of the actuation lever is configured to displace the propellant canister from the unactuated position to the actuated position;

and a puncture element positioned to puncture a propellant canister position and cause release of the propellant from the propellant canister when the propellant canister is displaced to the actuated position.

9. The device of claim 8 , wherein the actuation lever is an L-shaped lever arm, wherein a first member of the actuation lever is positioned to receive a contact force from an actuation button and a second member of the actuation lever perpendicular to the first member applies a contact force to the propellant canister upon actuation of the actuation button.

10. The device of claim 8 , wherein the actuation element comprises an actuation button exposed from the housing body, wherein depression of the actuation button in a direction towards the housing body drives the propellant canister into the puncture element, thereby puncturing the propellant canister.

11. The device of claim 8 , wherein the device further comprises a removeable cap configured to maintain the actuation element in an unactuated position.

12. The device of claim 8 , further comprising a lock configured to maintain the actuation element in an actuated position.

13. The device of claim 8 , further comprising a use indicator configured to provide an indication that the actuation element is in an actuated position.

14. The device of claim 8 , wherein the actuation element contains a sliding element exposed from the housing body, wherein the sliding element is slideable between an unactuated position that enables positioning of the propellant canister in the unactuated position and an actuated position that forces the propellant canister to the actuated position.

15. A device for delivery of a compound to a nasal cavity, the device comprising:

a housing body;

a propellant canister in the housing body containing a propellant which is different from the compound, the propellant canister displaceable between an unactuated position and an actuated position;

a puncture element in the housing body positioned to puncture the propellant canister position and cause release of the propellant from the propellant canister;

a diffuser in the housing body, acting as a one-way check-valve to diffuse the propellant upon its release from the propellant canister;

a dose holding chamber in the housing body, separated from the propellant canister, containing the compound, the dose holding chamber positioned such that the propellant flows into the dose holding chamber from the diffuser and causes the compound to be propelled from the dose holding chamber;

a nozzle positioned such that the released compound flows through the nozzle upon being propelled from the dose holding chamber for delivery to the nasal cavity; and

an actuation element comprising an actuation lever, wherein actuation of the actuation lever is configured to displace the propellant canister from the unactuated position to the actuated position.

16. The device of claim 15 , wherein the actuation lever is an L-shaped lever arm, wherein a first member of the actuation lever is positioned to receive a contact force from an actuation button and a second member of an actuation level perpendicular to the first member applies a contact force to the propellant canister upon actuation of the actuation button.

17. The device of claim 15 , wherein the actuation element comprises an actuation button exposed from the housing body, wherein depression of the actuation button in a direction towards the housing body drives the propellant canister into the puncture element, thereby puncturing the propellant canister.

18. The device of claim 15 , wherein the actuation element contains a sliding element exposed from the housing body, wherein the sliding element is slideable between an unactuated position that enables positioning of the propellant canister in the unactuated position and an actuated position that forces the propellant canister to the actuated position.

19. The device of claim 15 , wherein the device further comprises a removeable cap configured to maintain the actuation element in an unactuated position.

20. The device of claim 15 , further comprising a lock configured to maintain the actuation element in an actuated position.

Assignments (11)
SECURITY INTEREST Recorded Jun 5, 2025
From: WOODWARD SPECIALTY LLC
To: ALTER DOMUS (US) LLC
Reel/Frame 071324/0602 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2024
From: JN BIDCO LLC
To: WOODWARD SPECIALTY LLC
Reel/Frame 067062/0344 →
SECURITY INTEREST Recorded Mar 20, 2024
From: JN BIDCO LLC
To: ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
Reel/Frame 066837/0144 →
RELEASE OF SECURITY INTEREST Recorded Feb 28, 2024
From: OAKTREE FUND ADMINISTRATION, LLC
To: IMPEL PHARMACEUTICALS, INC.
Reel/Frame 066699/0566 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2024
From: IMPEL PHARMACEUTICALS INC.
To: JN BIDCO LLC
Reel/Frame 066601/0479 →
CORRECTIVE ASSIGNMENT TO CORRECT THE REMOVAL OF APPLICATION NUMBERS 12866448 AND APLICATION NUMBER 14292481 PREVIOUSLY RECORDED AT REEL: 059790 FRAME: 0722. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 4, 2022
From: IMPEL NEUROPHARMA, INC.
To: IMPEL PHARMACEUTICALS INC.
Reel/Frame 059855/0252 →
CHANGE OF NAME Recorded Apr 25, 2022
From: IMPEL NEUROPHARMA, INC.
To: IMPEL PHARMACEUTICALS INC.
Reel/Frame 059790/0722 →
SECURITY INTEREST Recorded Mar 17, 2022
From: IMPEL NEUROPHARMA, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 059300/0390 →
RELEASE OF SECURITY INTEREST Recorded Jul 6, 2021
From: AVENUE VENTURE OPPORTUNITIES FUND, L.P.
To: IMPEL NEUROPHARMA, INC.
Reel/Frame 056758/0495 →
SECURITY INTEREST Recorded Nov 5, 2020
From: IMPEL NEUROPHARMA, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND, L.P.
Reel/Frame 054287/0473 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 12, 2020
From: HOEKMAN, JOHN D.; LAVIN, ALBERT KENNETH; FULLER, CHRISTOPHER WILLIAM; KOHRING, CRAIG FREDERICK
To: IMPEL NEUROPHARMA, INC.
Reel/Frame 053470/0078 →
Continuity (2)
Provisional Application 62849735 · May 17, 2019
Related Publication 20200360627A1 · Nov 19, 2020